Allergy patients have up to 50% greater risk of being diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD). ELEANA is a clinical prospective study aiming at developing a machine learning-based algorithm that predicts the probability of a young child with allergies to develop ADHD based on clinical, laboratorial and ecosystem-related data.
The VIDA project focuses on the use of food waste to obtain vesicles with potential applications in health, namely in the development of innovative strategies to deliver drugs inside the cell.
(Less)PlasticBrain presented by the researcher Catarina Miranda. This project aims to replace plastic additives or plasticizers, which are highly toxic compounds that are added to plastics and migrate to the environment, contaminating the whole nature. They intend to test new additives that are biodegradable and harmless to humans and the environment using mathematical models and human brain models.
"NeuroCompute: Exploring the missing link between neuronal primary cilia dysfunction and neurophysiological properties using brain organoids and computational modelling" presented by Catarina Morais Seabra from Centre for Innovative Biomedicine and Biotechnology.
This project promotes the development of a new study model (cell organoids) for neurodevelopmental diseases, such as autism spectrum disorders. The work of this team will allow a deeper understanding of these diseases, reducing their social and economic impact.
“BioHab – a biofeedback solution for cognitive training systems” presented by
Marco Simões from DEI/FCTUC.